Shattuck Labs Inc (STTK)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$6.79-2.44%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · STTK
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenues | — | 1.0 | 5.7 | 1.7 | 0.7 |
| Operating Expenses & Income | |||||
| R&D Expenses | 39.3 | 35.3 | 67.2 | 74.3 | 82.9 |
| Operating Income | (55.8) | (51.5) | (80.6) | (92.0) | (103.3) |
| Earnings from Continuing Operations | |||||
| Interest & Investment Income | — | 2.7 | 5.2 | 4.7 | 1.6 |
| Other Non-Operating Income / Expenses | — | 2.7 | 5.2 | 4.7 | 1.4 |
| Asset Writedown | — | — | 0.2 | 0.3 | — |
| Income Tax Expense | — | — | — | 0.0 | 0.0 |
| Net Income | |||||
| Net Income | (52.6) | (48.8) | (75.4) | (87.3) | (101.9) |
| Per Share | |||||
| Basic EPS | (0.41) | (0.70) | (1.49) | (2.05) | (2.41) |
| Diluted EPS | (0.41) | (0.70) | (1.49) | (2.05) | (2.41) |
| Basic Weighted Avg Shares | 129.8 | 69.6 | 50.8 | 42.6 | 42.4 |
| Diluted Weighted Avg Shares | 129.8 | 69.6 | 50.8 | 42.6 | 42.4 |
| Supplemental | |||||
| EBITDA | — | (47.8) | (76.8) | (88.0) | (100.2) |
| EBIT | (55.8) | (51.5) | (80.6) | (92.0) | (103.3) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.